TABLE 2.

Voriconazole MIC results for 1,630 Candida isolates from phase III clinical studiesa

SpeciesNo. of isolates testedMIC (μg/ml)b
Range50%90%
C. albicans8860.004-160.0080.25
C. glabrata2850.008-160.54
C. tropicalis2400.004-160.060.25
C. parapsilosis1780.004-0.1250.030.06
C. krusei410.125-10.251
  • a Broth microdilution MICs determined in accordance with CLSI M27-A2.

  • b 50% and 90%, MIC encompassing 50% and 90% of isolates tested, respectively.